ClinConnect ClinConnect Logo
Search / Trial NCT06334640

Sleeping Quality and Chronic Ocular Diseases

Launched by ISTITUTO AUXOLOGICO ITALIANO · Mar 25, 2024

Trial Information

Current as of July 23, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial, titled "Sleeping Quality and Chronic Ocular Diseases," is designed to explore how sleep quality affects chronic eye diseases, such as macular degeneration and glaucoma. Researchers want to understand if better sleep can help improve eye health. The trial is currently looking for participants, and anyone between the ages of 65 and 74 is eligible. You can join the study if you have macular degeneration, glaucoma, or if you are a healthy volunteer without any other eye conditions.

If you decide to participate, you will be asked to share information about your sleep patterns and eye health. This study aims to gather important insights that could lead to better treatments and support for people with chronic eye diseases. Remember, this trial is open to both patients with specific eye diseases and healthy individuals, as long as they don’t have other eye disorders. Your participation could help improve our understanding of the relationship between sleep and eye health!

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients with macular degeneration or glaucoma or
  • Healthy volunteers
  • Exclusion Criteria:
  • - Patients with other ocular disorders

About Istituto Auxologico Italiano

Istituto Auxologico Italiano is a prominent Italian research institute dedicated to advancing medical science and improving patient care through innovative clinical research. With a strong focus on metabolic diseases, cardiovascular health, and neuropsychological disorders, the institute integrates clinical practice with cutting-edge research to foster the development of new therapeutic strategies. Committed to ethical standards and patient safety, Istituto Auxologico Italiano collaborates with various national and international partners, contributing significantly to the global medical community while ensuring high-quality care and support for its patients.

Locations

Milan, , Italy

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported